K.E. Naylor

2.9k total citations · 1 hit paper
30 papers, 2.0k citations indexed

About

K.E. Naylor is a scholar working on Orthopedics and Sports Medicine, Oncology and Molecular Biology. According to data from OpenAlex, K.E. Naylor has authored 30 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Orthopedics and Sports Medicine, 13 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in K.E. Naylor's work include Bone health and osteoporosis research (22 papers), Bone health and treatments (13 papers) and Bone Metabolism and Diseases (8 papers). K.E. Naylor is often cited by papers focused on Bone health and osteoporosis research (22 papers), Bone health and treatments (13 papers) and Bone Metabolism and Diseases (8 papers). K.E. Naylor collaborates with scholars based in United Kingdom, United States and Germany. K.E. Naylor's co-authors include Richard Eastell, Aubrey Blumsohn, R.A. Hannon, Jennifer Walsh, Nicola Peel, Eugène McCloskey, Fatma Gossiel, Phool Iqbal, Robert B. Fraser and Christian Fledelius and has published in prestigious journals such as American Journal of Clinical Nutrition, The Journal of Clinical Endocrinology & Metabolism and Journal of Bone and Mineral Research.

In The Last Decade

K.E. Naylor

28 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Use of CTX-I and PINP as bone turnover markers: National Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability

2017 231 citations Paweł Szulc, K.E. Naylor et al. Osteoporosis International profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
K.E. Naylor United Kingdom	19	1.2k	772	586	419	243	30	2.0k
Francesco Bertoldo Italy	33	1.2k 1.0×	876 1.1×	542 0.9×	511 1.2×	257 1.1×	90	2.6k
A. Joseph Foldes Israel	16	1.7k 1.4×	949 1.2×	595 1.0×	266 0.6×	436 1.8×	30	2.4k
Jessica Pepe Italy	29	1.1k 0.9×	1.1k 1.4×	589 1.0×	507 1.2×	625 2.6×	98	2.8k
Henning W. Woitge Germany	24	1.1k 0.9×	908 1.2×	783 1.3×	554 1.3×	160 0.7×	41	2.5k
Michael Pazianas United Kingdom	28	1.0k 0.8×	1.1k 1.4×	801 1.4×	166 0.4×	281 1.2×	80	2.5k
C. H. Chesnut United States	21	1.9k 1.5×	991 1.3×	681 1.2×	373 0.9×	514 2.1×	40	2.6k
Anne E. de Papp United States	22	1.9k 1.5×	1.2k 1.5×	770 1.3×	1.0k 2.4×	353 1.5×	36	2.9k
Joan M. Muhs United States	13	1.1k 0.9×	396 0.5×	438 0.7×	494 1.2×	197 0.8×	14	1.7k
M.A. Hansen Denmark	22	1.8k 1.5×	606 0.8×	672 1.1×	463 1.1×	687 2.8×	50	2.7k
Marcella D. Walker United States	30	1.1k 0.9×	813 1.1×	430 0.7×	753 1.8×	862 3.5×	76	2.9k

Countries citing papers authored by K.E. Naylor

Since Specialization

Citations

This map shows the geographic impact of K.E. Naylor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K.E. Naylor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K.E. Naylor more than expected).

Fields of papers citing papers by K.E. Naylor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K.E. Naylor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K.E. Naylor. The network helps show where K.E. Naylor may publish in the future.

Co-authorship network of co-authors of K.E. Naylor

This figure shows the co-authorship network connecting the top 25 collaborators of K.E. Naylor. A scholar is included among the top collaborators of K.E. Naylor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K.E. Naylor. K.E. Naylor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gossiel, Fatma, Margaret Paggiosi, K.E. Naylor, et al.. (2019). The effect of bisphosphosphonates on bone turnover and bone balance in postmenopausal women with osteoporosis: The T-score bone marker approach in the TRIO study. Bone. 131. 115158–115158. 12 indexed citations

Naylor, K.E., Eugène McCloskey, Richard Jacques, et al.. (2019). Clinical utility of bone turnover markers in monitoring the withdrawal of treatment with oral bisphosphonates in postmenopausal osteoporosis. Osteoporosis International. 30(4). 917–922. 33 indexed citations

Naylor, K.E., Mike Bradburn, Margaret Paggiosi, et al.. (2018). Effects of discontinuing oral bisphosphonate treatments for postmenopausal osteoporosis on bone turnover markers and bone density. Osteoporosis International. 29(6). 1407–1417. 35 indexed citations

Szulc, Paweł, et al.. (2018). Use of CTX-I and PINP as bone turnover markers: National Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability. Annales de biologie clinique. 76(4). 373–391. 14 indexed citations

Szulc, Paweł, et al.. (2017). Use of CTX-I and PINP as bone turnover markers: National Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability. Osteoporosis International. 28(9). 2541–2556. 231 indexed citations breakdown →

Eastell, Richard, et al.. (2017). DIAGNOSIS OF ENDOCRINE DISEASE: Bone turnover markers: are they clinically useful?. European Journal of Endocrinology. 178(1). R19–R31. 94 indexed citations

Gossiel, Fatma, Christopher Hoyle, Eugène McCloskey, et al.. (2016). The effect of bisphosphonate treatment on osteoclast precursor cells in postmenopausal osteoporosis: The TRIO study. Bone. 92. 94–99. 31 indexed citations

Naylor, K.E., Richard Jacques, Nicola Peel, Fatma Gossiel, & Richard Eastell. (2016). Response of bone turnover markers to raloxifene treatment in postmenopausal women with osteopenia. Osteoporosis International. 27(8). 2585–2592. 13 indexed citations

Walsh, Jennifer, Amy Evans, Simon Bowles, et al.. (2016). Free 25-hydroxyvitamin D is low in obesity, but there are no adverse associations with bone health. American Journal of Clinical Nutrition. 103(6). 1465–1471. 107 indexed citations

10.

Naylor, K.E., Richard Jacques, Margaret Paggiosi, et al.. (2015). Response of bone turnover markers to three oral bisphosphonate therapies in postmenopausal osteoporosis: the TRIO study. Osteoporosis International. 27(1). 21–31. 112 indexed citations

11.

Naylor, K.E., et al.. (2013). Adherence to raloxifene therapy: assessment methods and relationship with efficacy. Osteoporosis International. 24(11). 2879–2886. 9 indexed citations

12.

Naylor, K.E. & Richard Eastell. (2012). Bone turnover markers: use in osteoporosis. Nature Reviews Rheumatology. 8(7). 379–389. 199 indexed citations

13.

Paggiosi, Margaret, et al.. (2010). Performance of Quantitative Ultrasound Measurements of Bone for Monitoring Raloxifene Therapy. Journal of Clinical Densitometry. 13(4). 441–450. 4 indexed citations

14.

Naylor, K.E., et al.. (2009). The effect of cessation of raloxifene treatment on bone turnover in postmenopausal women. Bone. 46(3). 592–597. 29 indexed citations

15.

Glover, Sarah, Patrick Garnero, K.E. Naylor, Angela J. Rogers, & Richard Eastell. (2008). Establishing a reference range for bone turnover markers in young, healthy women. Bone. 42(4). 623–630. 120 indexed citations

16.

Pereda, Claudia Alejandra, R.A. Hannon, K.E. Naylor, & Richard Eastell. (2002). The impact of subcutaneous oestradiol implants on biochemical markers of bone turnover and bone mineral density in postmenopausal women. BJOG An International Journal of Obstetrics & Gynaecology. 109(7). 812–820. 15 indexed citations

17.

Newton, D., et al.. (2001). Long-term Retention of Injected Barium-133 in Man. Radiation Protection Dosimetry. 97(3). 231–240. 12 indexed citations

18.

Naylor, K.E., Richard Eastell, Karen E. Shattuck, Allen C. Alfrey, & Gordon L. Klein. (1999). Bone Turnover in Preterm Infants. Pediatric Research. 45(3). 363–366. 31 indexed citations

19.

Klein, Gordon L., David N. Herndon, William G. Goodman, et al.. (1995). Histomorphometric and biochemical characterization of bone following acute severe burns in children. Bone. 17(5). 455–460. 124 indexed citations

20.

Blumsohn, Aubrey, K.E. Naylor, Abdullah M. Assiri, & Richard Eastell. (1995). Different responses of biochemical markers of bone resorption to bisphosphonate therapy in Paget disease. Clinical Chemistry. 41(11). 1592–1598. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact